ENTA - Enanta Pharmaceuticals Inc.'s (ENTA) CEO Jay Luly on Q2 2021 Results - Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (ENTA) Q2 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants Jennifer Viera - Investor Relations Jay Luly - President and Chief Executive Officer Paul Mellett - Chief Financial Officer Nathalie Adda - Chief Medical Officer Conference Call Participants Brian Abrahams - RBC Capital Markets Yasmeen Rahimi - Piper Sandler Eric Joseph - J.P. Morgan Roy Buchanan - JMP Securities LLC Brian Skorney - Robert W. Baird & Co. William Lee - Wolfe Research, LLC Zegbeh Jallah - ROTH Capital Partners, LLC Presentation Operator Good afternoon and welcome to Enanta Pharmaceuticals Fiscal Second Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end of your prepared remarks. Please be advised that this call is being recorded. I would now like to turn the call over to Jennifer Viera, Investor
For further details see:
Enanta Pharmaceuticals, Inc.'s (ENTA) CEO Jay Luly on Q2 2021 Results - Earnings Call Transcript